228 related articles for article (PubMed ID: 25914961)
1. An Exercise Intervention During Chemotherapy for Women With Recurrent Ovarian Cancer: A Feasibility Study.
Mizrahi D; Broderick C; Friedlander M; Ryan M; Harrison M; Pumpa K; Naumann F
Int J Gynecol Cancer; 2015 Jul; 25(6):985-92. PubMed ID: 25914961
[TBL] [Abstract][Full Text] [Related]
2. Exercise Among Women With Ovarian Cancer: A Feasibility and Pre-/Post-Test Exploratory Pilot Study.
Zhang X; McClean D; Ko E; Morgan MA; Schmitz K
Oncol Nurs Forum; 2017 May; 44(3):366-374. PubMed ID: 28635971
[TBL] [Abstract][Full Text] [Related]
3. Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study.
Newton MJ; Hayes SC; Janda M; Webb PM; Obermair A; Eakin EG; Wyld D; Gordon LG; Beesley VL
BMC Cancer; 2011 Sep; 11():389. PubMed ID: 21899778
[TBL] [Abstract][Full Text] [Related]
4. Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial.
van Waart H; Stuiver MM; van Harten WH; Geleijn E; Kieffer JM; Buffart LM; de Maaker-Berkhof M; Boven E; Schrama J; Geenen MM; Meerum Terwogt JM; van Bochove A; Lustig V; van den Heiligenberg SM; Smorenburg CH; Hellendoorn-van Vreeswijk JA; Sonke GS; Aaronson NK
J Clin Oncol; 2015 Jun; 33(17):1918-27. PubMed ID: 25918291
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of a physical activity intervention in women with metastatic breast cancer.
Ligibel JA; Giobbie-Hurder A; Shockro L; Campbell N; Partridge AH; Tolaney SM; Lin NU; Winer EP
Cancer; 2016 Apr; 122(8):1169-77. PubMed ID: 26872302
[TBL] [Abstract][Full Text] [Related]
6. A Phase I Study Examining the Feasibility and Safety of an Aerobic Exercise Intervention in Patients With Rectal Cancer During and After Neoadjuvant Chemoradiotherapy.
Morielli AR; Usmani N; Boulé NG; Tankel K; Severin D; Nijjar T; Joseph K; Courneya KS
Oncol Nurs Forum; 2016 May; 43(3):352-62. PubMed ID: 27105196
[TBL] [Abstract][Full Text] [Related]
7. Effects of home-based exercise training on VO2 in breast cancer patients under adjuvant or neoadjuvant chemotherapy (SAPA): a randomized controlled trial.
Cornette T; Vincent F; Mandigout S; Antonini MT; Leobon S; Labrunie A; Venat L; Lavau-Denes S; Tubiana-Mathieu N
Eur J Phys Rehabil Med; 2016 Apr; 52(2):223-32. PubMed ID: 25986222
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Oncologist-Referred Exercise and Healthy Eating Programming as a Part of Supportive Adjuvant Care for Early Breast Cancer.
Kirkham AA; Van Patten CL; Gelmon KA; McKenzie DC; Bonsignore A; Bland KA; Campbell KL
Oncologist; 2018 Jan; 23(1):105-115. PubMed ID: 28982801
[TBL] [Abstract][Full Text] [Related]
9. High Efficacy and Low Toxicity of the Modified Docetaxel and Carboplatin Protocol in Patients with Recurrent Ovarian Cancer-A Phase 2 Cohort Study.
Bruchim I; Weeg N; Alpert Y; Sade D; Piura E; Fishman A
Int J Gynecol Cancer; 2016 May; 26(4):640-7. PubMed ID: 27101523
[TBL] [Abstract][Full Text] [Related]
10. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial.
Adamsen L; Quist M; Andersen C; Møller T; Herrstedt J; Kronborg D; Baadsgaard MT; Vistisen K; Midtgaard J; Christiansen B; Stage M; Kronborg MT; Rørth M
BMJ; 2009 Oct; 339():b3410. PubMed ID: 19826172
[TBL] [Abstract][Full Text] [Related]
11. A randomized pilot study with daily walking during adjuvant chemotherapy for patients with breast and colorectal cancer.
Backman M; Wengström Y; Johansson B; Sköldengen I; Börjesson S; Tärnbro S; Berglund Å
Acta Oncol; 2014 Apr; 53(4):510-20. PubMed ID: 24460069
[TBL] [Abstract][Full Text] [Related]
12. Effects of nurse-led home-based exercise & cognitive behavioral therapy on reducing cancer-related fatigue in patients with ovarian cancer during and after chemotherapy: A randomized controlled trial.
Zhang Q; Li F; Zhang H; Yu X; Cong Y
Int J Nurs Stud; 2018 Feb; 78():52-60. PubMed ID: 28939343
[TBL] [Abstract][Full Text] [Related]
13. Exercise in patients with non-small cell lung cancer.
Kuehr L; Wiskemann J; Abel U; Ulrich CM; Hummler S; Thomas M
Med Sci Sports Exerc; 2014 Apr; 46(4):656-63. PubMed ID: 24042307
[TBL] [Abstract][Full Text] [Related]
14. Quantifying physical activity and the associated barriers for women with ovarian cancer.
Mizrahi D; Naumann F; Broderick C; Samara J; Ryan M; Friedlander M
Int J Gynecol Cancer; 2015 May; 25(4):577-83. PubMed ID: 25628105
[TBL] [Abstract][Full Text] [Related]
15. The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer.
Headley JA; Ownby KK; John LD
Oncol Nurs Forum; 2004 Sep; 31(5):977-83. PubMed ID: 15378098
[TBL] [Abstract][Full Text] [Related]
16. Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
Del Carmen MG; Supko JG; Horick NK; Rauh-Hain JA; Clark RM; Campos SM; Krasner CN; Atkinson T; Birrer MJ
Cancer; 2016 Nov; 122(21):3297-3306. PubMed ID: 27421044
[TBL] [Abstract][Full Text] [Related]
17. The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy.
Quist M; Adamsen L; Rørth M; Laursen JH; Christensen KB; Langer SW
Integr Cancer Ther; 2015 Jul; 14(4):341-9. PubMed ID: 25800229
[TBL] [Abstract][Full Text] [Related]
18. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.
King MT; Stockler MR; Butow P; O'Connell R; Voysey M; Oza AM; Gillies K; Donovan HS; Mercieca-Bebber R; Martyn J; Sjoquist K; Friedlander ML
Int J Gynecol Cancer; 2014 Jun; 24(5):865-73. PubMed ID: 24844220
[TBL] [Abstract][Full Text] [Related]
19. An exercise and nutrition intervention for ovarian cancer patients during and after first-line chemotherapy (BENITA study): a randomized controlled pilot trial.
Maurer T; von Grundherr J; Patra S; Jaeger A; Becher H; Schmalfeldt B; Zyriax BC; Chang-Claude J
Int J Gynecol Cancer; 2020 Apr; 30(4):541-545. PubMed ID: 31796532
[TBL] [Abstract][Full Text] [Related]
20. Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?
Backes FJ; Richardson DL; McCann GA; Smith B; Salani R; Eisenhauer EL; Fowler JM; Copeland LJ; Cohn DE; O'Malley DM
Int J Gynecol Cancer; 2013 Jun; 23(5):833-8. PubMed ID: 23640292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
